Starboard's Jeff Smith told Pfizer in a meeting last week that they need to improve their return on investments in R&D and ...

A London-based investment firm accused a hedge fund of misusing trade secrets to set up its own lucrative fund, according to ...

In the telling of Scott Maidel, a 20-year volatility pro, it’s official: the options-selling boom across Wall Street has now ...

With shareholder engagement becoming increasingly prevalent among public companies, activist hedge funds are playing more of ...

Former Goldman Sachs investment banking associate Jack Ingles has purchased a stake 10 per cent in Premiership Rugby team ...

While opinion polls predict a close race between Democratic nominee Kamala Harris and Republican nominee Donald Trump, ...

Activist hedge fund Starboard Value's chief executive officer said on Tuesday that drugmaker Pfizer's board needs to hold ...

The titan made headlines in 2018 for his four-floor, $58.5 million investment at 9 West Walton, located in the city’s ...

Currently, financial markets are experiencing a mix of optimism and caution as investors react to changing economic ...

Israel Englander is a billionaire hedge fund manager and serves as the CEO of Millennium Management. During the second ...

We recently published a list of 10 AI Stocks to Watch for the Rest of 2024. In this article, we are going to take a look at ...

Activist hedge fund Starboard Value believes the root cause of Pfizer’s issues are the low expected returns on its research and development investments, including investments done both internally and ...